Announced details
Regenerative medicine aimed at improving motor symptoms in patients with Parkinson’s disease
住友ファーマ株式会社, RACTHERA, and a Kyoto University joint research group were the award recipients. RACTHERA is a joint venture between 住友化学 and Sumitomo Pharma Co.,Ltd. The award recognized the results of joint research with Kyoto University.
An organization that recognizes achievements in research, technology development and the promotion of industrialization in the fields of bioscience, biotechnology and bioindustry. Other details, including its location, representative, capital and year founded, are Not disclosed.
10th Bioindustry Award
Japan Bioindustry Association (JBA)
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
Japan Bioindustry Association (JBA) website
| Item | Details |
|---|---|
| Names of Products / Services Covered | Regenerative medicine product “アムシェプリ®” |
| Counterparty | Japan Bioindustry Association (JBA) |
| Counterparty overview | An organization that recognizes achievements in research, technology development and the promotion of industrialization in the fields of bioscience, biotechnology and bioindustry. Other details, including its location, representative, capital and year founded, are Not disclosed. |
| Relationship with the Company | 住友ファーマ株式会社, RACTHERA, and a Kyoto University joint research group were the award recipients. RACTHERA is a joint venture between 住友化学 and Sumitomo Pharma Co.,Ltd. The award recognized the results of joint research with Kyoto University. |
| Applicable area | Regenerative medicine aimed at improving motor symptoms in patients with Parkinson’s disease |
| Award/certification name | 10th Bioindustry Award |
| Awarding / certifying body | Japan Bioindustry Association (JBA) |
| Source | Japan Bioindustry Association (JBA) website |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The development of this product was recognized for demonstrating an ideal model of industry-academia collaboration that seamlessly connected basic research with practical implementation, and for paving the way to establishing regenerative medicine as a sustainable bioindustry.